Clinical Trial Update: Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC [Phase 2]

View source ↗

Summary

An ongoing Phase 2 clinical trial assessing the efficacy and safety of a PD-1 inhibitor in combination with chemotherapy for poorly differentiated locally advan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING